Pages that link to "Q33560188"
Jump to navigation
Jump to search
The following pages link to A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies (Q33560188):
Displaying 27 items.
- Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach (Q26774013) (← links)
- Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. (Q30249670) (← links)
- Tracheo-Esophageal Fistula (TEF) in a Newborn Following Maternal Antenatal Exposure to Olanzapine (Q37568684) (← links)
- A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium (Q38241431) (← links)
- One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder. (Q38382635) (← links)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio (Q38395937) (← links)
- Antipsychotic use in pregnancy (Q38498051) (← links)
- Use of psychotropic drugs during pregnancy and breast-feeding. (Q38582061) (← links)
- Mood stabilizers in pregnancy and child developmental outcomes: A systematic review (Q38616400) (← links)
- Managing Your Own Mood Lability: Use of Mood Stabilizers and Antipsychotics in Pregnancy (Q38674230) (← links)
- Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database. (Q38701070) (← links)
- Bipolar Disorder in Pregnancy and Postpartum: Principles of Management. (Q38701750) (← links)
- Atypical antipsychotic use and outcomes in an urban maternal mental health service (Q38718876) (← links)
- Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making (Q38811512) (← links)
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders (Q38815462) (← links)
- A review of the safety of clozapine during pregnancy and lactation (Q38972443) (← links)
- Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations (Q39474187) (← links)
- Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. (Q41433722) (← links)
- Lithium exposure during pregnancy: outcomes for women who attended a specialist antenatal clinic (Q47314318) (← links)
- Clinical characteristics of maternal mental health service users treated with mood stabilizing or antipsychotic medication (Q47332870) (← links)
- Bipolar Disorder in Pregnancy: A Review of Pregnancy Outcomes (Q47586027) (← links)
- Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research (Q47645310) (← links)
- The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness (Q47754564) (← links)
- Adverse obstetric outcomes during delivery hospitalizations complicated by suicidal behavior among US pregnant women (Q49979649) (← links)
- The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review (Q61628767) (← links)
- Meningomyelocele on Exposure to Clozapine During Perinatal Period (Q92484447) (← links)
- Use of Antipsychotic Drugs During Pregnancy (Q98290874) (← links)